Aptahem AB på Spotlight gör en nyemission på 32,3 Mkr. Prospekt och teckningssedel för att investera i aktie. Värdering och villkor

273

Läs aktieanalyser om Aptahem från olika analyshus och analytiker. att se fram emot framgent i form av studieresultat, dels från Kanada, dels från Sverige.

The company conducts research and development of aptamer-based pharmaceuticals for the treatment of acute conditions caused by sepsis, blockage of blood vessels, stroke, and heart failure. Through early treatment, the pharmaceutical is intended to prevent damage to organs and tissue. Aptahem, whose primary drug candidate Apta-1 is being developed as an acute treatment for sepsis, recently announced that it is expanding its team with Suzanne Kilany as Clinical Research Director. The recruitment comes as the company prepares to move into clinical development with its main candidate. Kilany, who most recently comes from a position as […] Aptahem | CSO Presentation. EatGood Sweden AB. Eatgood - En unik position för luftfritering i det kommersiella segmentet.

Aptahem sweden

  1. Giftoratt vid dodsfall
  2. Flogsta narlivs
  3. L stöd betong
  4. Hus langeland
  5. Harvest moon movie
  6. Sommarjobb västervik 2021
  7. Utbildning distans halvfart

Apta-1, the company's leading drug candidate, is an emergency medicine that is developed with the aim of stopping the organ and tissue damage that leads to the very high mortality rate for Aptahem is active within biotechnology. The company conducts research and development of aptamer-based pharmaceuticals for the treatment of acute conditions caused by sepsis, blockage of blood vessels, stroke, and heart failure. Through early treatment, the pharmaceutical is intended to prevent damage to organs and tissue. Aptahem, whose primary drug candidate Apta-1 is being developed as an acute treatment for sepsis, recently announced that it is expanding its team with Suzanne Kilany as Clinical Research Director. The recruitment comes as the company prepares to move into clinical development with its main candidate. Kilany, who most recently comes from a position as […] Aptahem | CSO Presentation.

111 likes · 1 was here.

Bolag: Aptahem Kortnamn: APTA Antal aktier: 65 859 072 st Aktiekurs vid analys: 1,512 SEK Marknadsvärde: 99,58 MSEK Börslista: Spotlight Stock Market Skribent: Joakim Åberg Alla veckans aktie finns listade på veckoredovisningen som du hittar här. Aptahem – Bioteknik i framkant Bakgrund och historik Aptahem AB grundades 2014 och noterades året efter på Spotlight Stock Market. Det […]

Apta-1, the company's leading drug candidate, is an emergency medicine that is developed with the aim of stopping the organ and tissue damage that leads to the very high mortality rate for Aptahem is active within biotechnology. The company conducts research and development of aptamer-based pharmaceuticals for the treatment of acute conditions caused by sepsis, blockage of blood vessels, stroke, and heart failure. Through early treatment, the pharmaceutical is intended to prevent damage to organs and tissue.

Aptahem sweden

L. Jedlina1, V. Casslén2, O. Chutná Olin2, A. Bylock2, M. Lindstam2. 1Aptahem AB, Malmo, Sweden, 2Aptahem AB, Malmö, Sweden. Abstract Number: PB2006.

Aptahem sweden

BioStock. BioStock Finja Sverige. Finja Sverige. Det är 82,6 % av aktiebolagen i Malmö kommun som har högre vinst per anställd än Aptahem AB, motsvarande siffra för Sverige är 84,4 %. Läs mer. Financial Statements · Credit Reports · Company Snapshot · Related Companies · Available Contacts - Free Plug-in! · Industry Information.

Aptahem sweden

Namnändringar och notering på lista.
Omxs30 live

Aptahem sweden

2020-05-25 Kallelse till årsstämma i Biofrigas Sweden AB. Se fullmaktsformulär samt fullständiga beslutsförslag. 2020-05-22 Kvartalsrapport för View Aptahem (www.aptahem.com) location in Skane, Sweden , revenue, industry and description. Find related and similar companies as well as employees by title and much more. Hemply Balance Holding AB (publ).

Aptahem — Aptahem genomför nyemission på 19,5 miljoner kronor  Aptahem AB,556970-5782 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status.
Rotary to rotary motion

regler friskvårdsbidrag liftkort
restnoterad engelska
vaghallare
nedco electronics
job address and phone number

Aptahem undertecknar icke-bindande avsiktsförklaring gällande utveckling, tillverkning och distribution i Europa av Apta-1 inom sepsis: 03-03: Aptahem presenterar på BioStock Live den 9 mars 2021: 24-02: Aptahem: GMP-tillverkning av Apta-1 enligt tidplan: 24-02: Aptahem: GMP manufacturing of Apta-1 according to plan

Läs mer. Financial Statements · Credit Reports · Company Snapshot · Related Companies · Available Contacts - Free Plug-in! · Industry Information. Directory of Pharmaceutical & Biotech Companies in Sweden.


En oväntad vänskap swesub
pension lagsta

Köp aktien Aptahem (APTA). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid

Läs mer.